Grifols, S.A.
NASDAQ:GRFSDrug Manufacturers - General
+$0.03 today
- Market cap
- $7.17B
- Beta
- 1.17
- P/E (TTM)
- 14.7
- EPS (TTM)
- $0.61
- Dividend yield
- 1.67%
Volume 0.59M
Average 0.69M
GRFS Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Grifols, S.A.NASDAQ: GRFS
Net Receivables · Q2 FY2026 · quarter ended Jun 2026
Net receivables falls 5.1% from a year ago
Net receivables stood at €1.19B at the end of Q2 FY2026, down 5.1% from a year earlier and up 24.0% from the prior quarter. Over 3 fiscal years it compounded at +2.9% a year.
Context
- Net receivables amounted to 5.9% of total assets at the end of Q2 FY2026, down 0.4 pp from a year earlier.
- Net receivables increased in 1 of the last 3 fiscal years.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -5.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
EUR · from the balance sheet
- Latest · FY2025
- 844.64M EUR
- Year-over-year change
- -21.7%
- 4-year CAGR
- +18.1%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 844.64M | -21.7% |
| FY2024 | 2024-12-31 | 1.08B | +55.8% |
| FY2023 | 2023-12-31 | 692.86M | -10.5% |
| FY2022 | 2022-12-31 | 774.2M | +78.3% |
| FY2021 | 2021-12-31 | 434.14M | — |
Net Receivables vs competitors
How GRFS compares with its peers on the latest reported figures
- Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -5.1% is the 7th highest of 9, against a peer median of +9.6%.
- Net receivables amounts to 5.9% of total assets for GRFS, versus a peer median of 7.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $8.6B USD | +7.9% | +8.4% | 7.9% | |
| Sep 2026 | $2.77B USD | -7.4% | +3.0% | 5.5% | |
| Jun 2026 | €1.19B EUR | -5.1% | +2.9% | 5.9% | |
| Mar 2026 | $486.7M USD | +11.4% | -10.7% | 8.6% | |
| Jun 2026 | $441.8M USD | -6.0% | -1.5% | 4.3% | |
| Jun 2026 | $216.07M USD | +7.6% | +6.6% | 9.1% | |
| Sep 2026 | $209.8M USD | +14.1% | +0.3% | 8.0% | |
| Jun 2026 | $138.23M USD | +26.0% | +117.0% | 20.2% | |
| Jun 2026 | $31.14M USD | +11.7% | -44.2% | 5.2% | |
| Peer median (excluding GRFS) | — | +9.6% | +1.7% | 7.9% | |
Competitors are the stored peer set for GRFS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 655.49M | 549.21M | 529.58M | 979.78M | 824.65M |
| Short-term Investments | 2.03B | 31.03M | 116.47M | 21.18M | 0 |
| Net Receivables | 434.14M | 774.2M | 692.86M | 1.08B | 844.64M |
| Inventory | 2.26B | 3.24B | 3.48B | 3.56B | 3.29B |
| Other Current Assets | 131.63M | 80.88M | 1.31B | 78.58M | 100.96M |
| Total Current Assets | 5.51B | 4.69B | 6.13B | 5.73B | 5.07B |
| Property, Plant & Equipment (Net) | 3.34B | 4.28B | 4.19B | 4.31B | 4.05B |
| Goodwill | 6.23B | 7.01B | 6.8B | 7.4B | 6.83B |
| Intangible Assets | 1B | 2.95B | 1.21B | 2.93B | 2.73B |
| Long-term Investments | 2.27B | 1.99B | 451.9M | 528.97M | 592.75M |
| Tax Assets | 0 | 174.92M | 0 | 341.67M | 461.8M |
| Other Non-current Assets | 882.61M | 124.19M | 2.21B | 167.72M | 15.99M |
| Total Non-current Assets | 13.72B | 16.54B | 14.86B | 15.68B | 14.68B |
| Total Assets | 19.23B | 21.23B | 20.99B | 21.41B | 19.75B |
| Account Payables | 628.99M | 787.96M | 822.95M | 852.31M | 840.64M |
| Short-term Debt | 2.35B | 578.92M | 916.51M | 523.13M | 385.84M |
| Tax Payables | 0 | 15.69M | 0 | 84.99M | 0 |
| Deferred Revenue | 0 | 37.83M | 0 | 70.87M | 76.97M |
| Other Current Liabilities | 119.44M | 381.59M | 108.6M | 81.95M | 459.8M |
| Total Current Liabilities | 3.47B | 2.02B | 2.33B | 2.16B | 2.02B |
| Long-term Debt | 6.94B | 8.15B | 8.99B | 8.42B | 7.39B |
| Deferred Tax Liabilities | 0 | 1.03B | 0 | 1.01B | 906.61M |
| Deferred Revenue (Non-current) | 0 | 15.12M | 0 | 13.94M | 0 |
| Other Non-current Liabilities | 675.34M | 1.12B | 1.16B | 170.46M | 854.64M |
| Total Non-current Liabilities | 8.44B | 11.23B | 11.15B | 10.64B | 10.12B |
| Total Liabilities | 11.92B | 13.25B | 13.48B | 12.8B | 12.13B |
| Common Stock | 119.6M | 119.6M | 119.6M | 119.6M | 119.95M |
| Retained Earnings | 248M | 0 | 79.36M | 156.92M | 0 |
| Accumulated OCI | 4.41B | 4.78B | 4.41B | 4.83B | 4.37B |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 1.79B | 2.33B | 2.15B | 2.72B | 2.33B |
| Total Equity | 7.32B | 7.98B | 7.51B | 8.61B | 7.6B |
| Total Debt | 10.17B | 9.75B | 11.02B | 10.09B | 8.74B |
| Net Debt | 9.51B | 9.2B | 10.49B | 9.11B | 7.92B |
Grifols, S.A.
NASDAQ:GRFS
Intrinsic Alpha fair value
Locked
Current Price
$8.47
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.